Tier 3 · Filer Universe

GYRE THERAPEUTICS, INC.

GYRE · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$6.44
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001124105
Liquidity rank
#4751
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$116.59M2025-12-310001193125-26-106251
Annual diluted EPS0.022025-12-310001193125-26-106251
Quarterly revenue$29.11M2026-06-300001193125-26-340448
Quarterly diluted EPS-0.122026-06-300001193125-26-340448

SEC EDGAR Frames batch generated 2026-08-24T22:57:10.520Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerISRG · Tier 1 peerPFE · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames